Basic Information
RNALocate ID: RLID:11002548
RNA Symbol: hsa-miR-382-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-382
RNA ID: miRBase:MIMAT0000737
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 18589210
Tissue/Cell Line: Serum
Method: Microarray
Description: Association of microRNA with peripheral blood-derived tumor exosomes compared with microRNA isolated from their corresponding tumors. Data are collected from Table 1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002047 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:11002549 Exosome Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11002550 Exosome Jurkat-derived T cell line (J77cl20) 21505438
RLID:11002551 Exosome Brain tissue 23382797
RLID:11002552 Exosome Plasma 23663360
RLID:11002553 Exosome B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells 25242326
RLID:11002554 Microvesicle Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) 20615901
RLID:11002555 Microvesicle Seminal plasma 23539611
RLID-D:11000126 Exosome Blood
RLID-D:11000425 Microvesicle Blood|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-382-5p Pheochromocytoma MNDR-E-MI-47191
MNDR hsa-miR-382-5p Oral squamous cell carcinoma MNDR-E-MI-47192
MNDR hsa-miR-382-5p Medulloblastoma MNDR-E-MI-47193
MNDR hsa-miR-382-5p High-grade serous ovarian carcinoma MNDR-E-MI-47194
MNDR hsa-miR-382-5p Uterine corpus endometrial carcinoma MNDR-E-MI-47195
MNDR hsa-miR-382-5p Lymphoma MNDR-E-MI-47196
MNDR hsa-miR-382-5p Estrogen-receptor positive breast cancer MNDR-E-MI-47197
MNDR hsa-miR-382-5p Estrogen-receptor negative breast cancer MNDR-E-MI-47198
MNDR hsa-miR-382-5p Progesterone-receptor positive breast cancer MNDR-E-MI-47199
MNDR hsa-miR-382-5p Progesterone-receptor negative breast cancer MNDR-E-MI-47200
MNDR hsa-miR-382-5p Her2-receptor positive breast cancer MNDR-E-MI-47201
MNDR hsa-miR-382-5p Niemann-pick disease type c MNDR-E-MI-47202
MNDR hsa-miR-382-5p Dermatomyositis MNDR-E-MI-47203
MNDR hsa-miR-382-5p Gastric cancer MNDR-E-MI-47204
MNDR hsa-miR-382-5p Alzheimer disease MNDR-E-MI-47205
MNDR hsa-miR-382-5p Dysautonomia familial MNDR-E-MI-47206
MNDR hsa-miR-382-5p Muscular dystrophy duchenne MNDR-E-MI-47207
MNDR hsa-miR-382-5p Head and neck cancer MNDR-E-MI-47208
MNDR hsa-miR-382-5p Huntington disease MNDR-E-MI-47209
MNDR hsa-miR-382-5p Chorea MNDR-E-MI-47210
MNDR hsa-miR-382-5p Lung cancer MNDR-E-MI-47211
MNDR hsa-miR-382-5p Fragile x syndrome MNDR-E-MI-47212
MNDR hsa-miR-382-5p Parkinson disease MNDR-E-MI-47213
MNDR hsa-miR-382-5p Niemann-pick disease MNDR-E-MI-47214
MNDR hsa-miR-382-5p Breast cancer MNDR-E-MI-47215
MNDR hsa-miR-382-5p Squamous cell carcinoma MNDR-E-MI-47216
MNDR hsa-miR-382-5p Thyroid cancer MNDR-E-MI-47217
MNDR hsa-miR-382-5p Pituitary neoplasms MNDR-E-MI-47218
MNDR hsa-miR-382-5p Pancreatic cancer MNDR-E-MI-47219
MNDR hsa-miR-382-5p Melanoma MNDR-E-MI-47220
MNDR hsa-miR-382-5p Nephroblastoma MNDR-E-MI-47221
MNDR hsa-miR-382-5p Ischemic attack transient MNDR-E-MI-47222
MNDR hsa-miR-382-5p Colon adenocarcinoma MNDR-E-MI-47223
MNDR hsa-miR-382-5p Familial ovarian cancer MNDR-E-MI-47224
MNDR hsa-miR-382-5p Carcinoma ductal breast MNDR-E-MI-47225
MNDR hsa-miR-382-5p Glioblastoma MNDR-E-MI-47226
MNDR hsa-miR-382-5p Glioma MNDR-E-MI-47227
MNDR hsa-miR-382-5p Nemaline myopathy MNDR-E-MI-47228
MNDR hsa-miR-382-5p Chordoma MNDR-E-MI-47229
MNDR hsa-miR-382-5p Amyotrophic lateral sclerosis MNDR-E-MI-47230
MNDR hsa-miR-382-5p Osteosarcoma MNDR-E-MI-47231
MNDR hsa-miR-382-5p Meningioma MNDR-E-MI-47232
MNDR hsa-miR-382-5p Uterine cancer MNDR-E-MI-47233
MNDR hsa-miR-382-5p Gastric adenocarcinoma MNDR-E-MI-47234
MNDR hsa-miR-382-5p Bone-invasive pituitary adenoma MNDR-E-MI-47235
MNDR hsa-miR-382-5p Lung squamous cell carcinoma MNDR-E-MI-47236
MNDR hsa-miR-382-5p Lung adenocarcinoma MNDR-E-MI-47237
MNDR hsa-miR-382-5p Adrenocortical carcinoma MNDR-E-MI-47238
MNDR hsa-miR-382-5p Thyroid carcinoma MNDR-E-MI-47239
MNDR hsa-miR-382-5p Ovarian carcinoma MNDR-E-MI-47240
MNDR hsa-miR-382-5p Bladder urothelial carcinoma MNDR-E-MI-47241
MNDR hsa-miR-382-5p Pancreatic adenocarcinoma MNDR-E-MI-47242
MNDR hsa-miR-382-5p Carcinoma renal cell MNDR-E-MI-47243
MNDR hsa-miR-382-5p Kidney renal papillary cell carcinoma MNDR-E-MI-47244
MNDR hsa-miR-382-5p Clear cell renal cell carcinoma MNDR-E-MI-47245
MNDR hsa-miR-382-5p Adenocarcinoma of esophagus MNDR-E-MI-47246
MNDR hsa-miR-382-5p Esophageal cancer MNDR-E-MI-47247
MNDR hsa-miR-382-5p Prolactinoma MNDR-E-MI-47248
MNDR hsa-miR-382-5p Synovial sarcoma MNDR-E-MI-47249
MNDR hsa-miR-382-5p Head and neck squamous cell carcinoma MNDR-E-MI-47250
MNDR hsa-miR-382-5p Breast invasive carcinoma MNDR-E-MI-47251
MNDR hsa-miR-382-5p Familiar ovarian carcinoma MNDR-E-MI-47252
MNDR hsa-miR-382-5p Retinoblastoma MNDR-E-MI-47253
MNDR hsa-miR-382-5p Skin cutaneous melanoma MNDR-E-MI-47254
MNDR hsa-miR-382-5p Skin melanoma MNDR-E-MI-47255
MNDR hsa-miR-382-5p Colorectal cancer MNDR-E-MI-47256
MNDR hsa-miR-382-5p Nasopharynx carcinoma MNDR-E-MI-47257
MNDR hsa-miR-382-5p Nasopharyngeal cancer MNDR-E-MI-47258
MNDR hsa-miR-382-5p Polymyositis MNDR-E-MI-47259
MNDR hsa-miR-382-5p Cerebral hemorrhage traumatic MNDR-E-MI-47260
MNDR hsa-miR-382-5p Stroke lacunar MNDR-E-MI-47261
MNDR hsa-miR-382-5p Breast cancer her3+ negative MNDR-E-MI-47262
MNDR hsa-miR-382-5p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-47263
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ATXN1 Homo sapiens RR00165932
TOP